Clinical Trial Update: Bryostatin and Vincristine in B-Cell Malignancies [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating Bryostatin-1 in combination with Vincristine in several recurrent or refractory B-cell malignancies; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burkitt Lymphoma
• Chronic Lymphocytic Leukemia
• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma
• Immunoblastic Large Cell Lymphoma
• Lymphoblastic Lymphoma
• Mantle Cell Lymphoma
• Multiple Myeloma

Drugs mentioned

• Bryostatin-1 (bryostatin-1)
• Vincristine (vincristine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma | Phase 1 | Status: COMPLETED